Literature DB >> 23377968

MicroRNA-regulated networks: the perfect storm for classical molecular biology, the ideal scenario for systems biology.

Julio Vera1, Xin Lai, Ulf Schmitz, Olaf Wolkenhauer.   

Abstract

MicroRNAs (miRNAs) are involved in many regulatory pathways some of which are complex networks enriched in regulatory motifs like positive or negative feedback loops or coherent and incoherent feedforward loops. Their complexity makes the understanding of their regulation difficult and the interpretation of experimental data cumbersome. In this book chapter we claim that systems biology is the appropriate approach to investigate the regulation of these miRNA-regulated networks. Systems biology is an interdisciplinary approach by which biomedical questions on biochemical networks are addressed by integrating experiments with mathematical modelling and simulation. We here introduce the foundations of the systems biology approach, the basic theoretical and computational tools used to perform model-based analyses of miRNA-regulated networks and review the scientific literature in systems biology of miRNA regulation, with a focus on cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377968     DOI: 10.1007/978-94-007-5590-1_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  22 in total

1.  Polypyrimidine tract-binding protein blocks miRNA-124 biogenesis to enforce its neuronal-specific expression in the mouse.

Authors:  Kyu-Hyeon Yeom; Simon Mitchell; Anthony J Linares; Sika Zheng; Chia-Ho Lin; Xiao-Jun Wang; Alexander Hoffmann; Douglas L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-06       Impact factor: 11.205

Review 2.  MicroRNAs: master regulators of drug resistance, stemness, and metastasis.

Authors:  Umar Raza; Jitao David Zhang; Ozgür Sahin
Journal:  J Mol Med (Berl)       Date:  2014-02-09       Impact factor: 4.599

3.  MicroRNA-29c Correlates with Neuroprotection Induced by FNS by Targeting Both Birc2 and Bak1 in Rat Brain after Stroke.

Authors:  Li-Gang Huang; Jin-Pin Li; Xiao-Min Pang; Chun-Yong Chen; Hui-Yao Xiang; Ling-Bo Feng; Sheng-You Su; Sheng-Hua Li; Lei Zhang; Jing-Li Liu
Journal:  CNS Neurosci Ther       Date:  2015-02-10       Impact factor: 5.243

4.  Dual Fluorescence Reporter Based Analytical Flow Cytometry for miRNA Induced Regulation in Mammalian Cells.

Authors:  Nicolas Lemus-Diaz; Liezel Tamon; Jens Gruber
Journal:  Bio Protoc       Date:  2018-09-05

5.  Cooperative gene regulation by microRNA pairs and their identification using a computational workflow.

Authors:  Ulf Schmitz; Xin Lai; Felix Winter; Olaf Wolkenhauer; Julio Vera; Shailendra K Gupta
Journal:  Nucleic Acids Res       Date:  2014-05-29       Impact factor: 16.971

Review 6.  Computational systems biology approaches to anti-angiogenic cancer therapeutics.

Authors:  Stacey D Finley; Liang-Hui Chu; Aleksander S Popel
Journal:  Drug Discov Today       Date:  2014-10-05       Impact factor: 7.851

7.  p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA.

Authors:  Feng Yu; Cameron P Bracken; Katherine A Pillman; David M Lawrence; Gregory J Goodall; David F Callen; Paul M Neilsen
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

8.  MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis.

Authors:  Xiao-Ying Huang; Jin-Guang Yao; Hong-Dong Huang; Chao Wang; Yun Ma; Qiang Xia; Xi-Dai Long
Journal:  Gastroenterol Res Pract       Date:  2013-09-24       Impact factor: 2.260

9.  Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expression.

Authors:  Christopher G Hill; Lilya V Matyunina; Deette Walker; Benedict B Benigno; John F McDonald
Journal:  BMC Syst Biol       Date:  2014-03-25

10.  MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.

Authors:  Yi-Xiao Liu; Xi-Dai Long; Zhi-Feng Xi; Yun Ma; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Tian-Yu Xing; Qiang Xia
Journal:  Biomed Res Int       Date:  2014-04-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.